- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05490823
Validation of a Smartphone App for Anemia Screening Among General Population
August 4, 2022 updated by: Haotian Lin, Sun Yat-sen University
Validation of a Smartphone App for Anemia Screening Among General Population: A Clinical Trial
The current standard for anemia screening, complete blood count, presents invasiveness, infrastructure requirements and high costs, leading to serious underestimation of anemia prevalence and insufficient care for anemia patients.
Here, the investigators established and validated an artificial intelligence system to achieve automatic detection of anemia based on patient-sourced images of fingernails and conjunctivae.
This system has been integrated into a smartphone app to be further validated through hospital-based and population-based clinical trials.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
1000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Recruiting
- Zhongshan Ophthalmic Center, Sun Yat-sen University
-
Contact:
- Haotian Lin, M.D., Ph.D
- Phone Number: 8613802793086
- Email: haot.lin@hotmail.com
-
Contact:
- Xiaohang Wu, M.D., Ph.D
- Phone Number: 8615913177657
- Email: wuxiaohang_zoc@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 87 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients should be aware of the contents and signed for the informed consent.
Exclusion Criteria:
- Patients who underwent ophthalmic or fingernail surgery in the past 30 days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Eligible patients for app-based anemia screening
Device: A smartphone app for anemia screening This app can achieve automatic detection of anemia based on patient-sourced images of fingernails and conjunctivae.
|
This app can achieve automatic detection of anemia based on patient-sourced images of fingernails and conjunctivae.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The proportion of accurate, mistaken and missed detection of this smartphone app.
Time Frame: 27 months
|
27 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2018
Primary Completion (Anticipated)
December 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
August 4, 2022
First Submitted That Met QC Criteria
August 4, 2022
First Posted (Actual)
August 8, 2022
Study Record Updates
Last Update Posted (Actual)
August 8, 2022
Last Update Submitted That Met QC Criteria
August 4, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AnemiaApp-2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingSevere Aplastic Anemia | Refractory Aplastic Anemia | Newly Diagnosed Aplastic Anemia
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Hungary, Italy, Spain, United Kingdom
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Netherlands, Germany, Italy, United Kingdom, United States, France
-
China Immunotech (Beijing) Biotechnology Co., Ltd.Not yet recruitingAutoimmune Hemolytic AnemiaChina
-
Peking Union Medical College HospitalNot yet recruiting
-
Chinese PLA General HospitalBeijing Friendship Hospital; Beijing 302 Hospital; The University of Hong Kong-Shenzhen... and other collaboratorsEnrolling by invitationSevere Aplastic Anemia | Severe Aplastic Anemia (SAA) | Severe Aplastic Anemia, RefractoryChina
-
Incyte CorporationTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom, Belgium
-
Chen MiaoNot yet recruiting
Clinical Trials on A smartphone app for anemia screening
-
University of WashingtonCompletedDepression | AnxietyUnited States
-
Centers for Disease Control and PreventionCompleted
-
Oslo Metropolitan UniversityVestre Viken Hospital Trust; Oslo University Hospital; University Hospital, Akershus and other collaboratorsCompletedGestational Diabetes MellitusNorway
-
Universidade Federal do ParanáCompletedAdolescent Behavior
-
Sir Run Run Shaw HospitalCompletedCigarette Smoking | Smartphone App-based Smoking CessationChina
-
University of Santiago de CompostelaMinisterio de Economía y Competitividad, Spain; Ministry of Work and Welfare...Completed
-
Picterus ASNorwegian University of Science and TechnologyTerminatedNeonatal JaundiceUganda
-
Children's Hospital Medical Center, CincinnatiVerizon Foundation; Luther FoundationCompleted
-
LMU KlinikumPreventicus GmbH; Versicherungskammer BayernActive, not recruiting
-
Hospital Moinhos de VentoNot yet recruiting